Jennifer Cogburn, MD in Iowa City, IA - Medicare Student in an Organized Health Care Education/Training Program

Jennifer Cogburn, MD is a medicare enrolled "Student In An Organized Health Care Education/training Program" physician in Iowa City, Iowa. Her current practice location is 200 Hawkins Dr, Iowa City, Iowa. You can reach out to her office (for appointments etc.) via phone at (319) 384-5078.

Jennifer Cogburn is licensed to practice in * (Not Available) (license number ) and she also participates in the medicare program. She does not accept medicare assignments directly but she may accept medicare through third-party (refer to Reassignment section below) and may also prescribe medicare part D drugs. Her NPI Number is 1295354140.

Contact Information

	Jennifer Cogburn, MD
	200 Hawkins Dr, Iowa City, IA 52242-1009
	(319) 384-5078
	Not Available

Physician's Profile

Full Name	Jennifer Cogburn
Gender	Female
Speciality	Student In An Organized Health Care Education/training Program
Location	200 Hawkins Dr, Iowa City, Iowa
Accepts Medicare Assignments	Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs.

NPI Data:

NPI Number: 1295354140
Provider Enumeration Date: 04/10/2020
Last Update Date: 05/29/2023

Medicare PECOS Information:

PECOS PAC ID: 6103249461
Enrollment ID: I20200706002587

Medical Identifiers

Medical identifiers for Jennifer Cogburn such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1295354140	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
207QS0010X	Family Medicine - Sports Medicine	R-12700 (Iowa)	Secondary
390200000X	Student In An Organized Health Care Education/training Program	(* (Not Available))	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Jennifer Cogburn is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Jennifer Cogburn, MD 200 Hawkins Dr, Iowa City, IA 52242-1009 Ph: (319) 384-5078	Jennifer Cogburn, MD 200 Hawkins Dr, Iowa City, IA 52242-1009 Ph: (319) 384-5078

News Archive

Health IT roundup: Buyers' remorse, usage survey

Huffington Post Investigative Fund: The federal government has made investing in electronic medical records a priority by channeling billions of dollars to help doctors and hospitals go paperless, "[b]ut there's also concern that the government may not be doing enough to ensure that taxpayer money isn't wasted on faulty systems. What's more, doctors often have little expertise in buying electronic health records, commonly called EHRs, and do not always know what questions to ask or what protections they should push for in their contracts, several industry consultants said in interviews."

Level of bacteria on fresh produce can vary according to income level: Study

No one wants a mixed salad tossed with extra bacteria, mold and yeast, but those are just what you might find when you try to eat a healthier diet in poorer neighborhoods. A new study shows that the level of bacteria found on the fresh produce can vary according to the income level of the neighborhoods where it is for sale.

UHC: Implementation of patient- and family-centered care improves quality of care for patients

Understanding the needs of patients and their families has several advantages for health care providers, including enhancing safety and helping to stem the increasing costs of medical errors and malpractice litigation. In fact, many academic medical centers are turning to implementation of patient- and family-centered care (PFCC) to improve the quality of care for patients.

New drug works better than current treatments for advanced kidney cancer

A new drug has been found superior to current treatments in slowing the growth of advanced kidney cancer in patients who became resistant to the first-line therapies that had kept it in check, according to results from a clinical trial led by Dana-Farber Cancer Institute.

Jennifer Cogburn, MD - Medicare Student in an Organized Health Care Education/Training Program in Iowa City, IA